# Intrathecal Tetanus Immunoglobulin to Treat Tetanus

> **NCT02999815** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oxford University Clinical Research Unit, Vietnam** · enrollment: 272 (actual)

## Conditions studied

- Tetanus

## Interventions

- **PROCEDURE:** Human tetanus immunoglobulin
- **PROCEDURE:** Intramuscular antitoxin

## Key facts

- **NCT ID:** NCT02999815
- **Lead sponsor:** Oxford University Clinical Research Unit, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-05-01
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2020-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02999815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02999815, "Intrathecal Tetanus Immunoglobulin to Treat Tetanus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02999815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*